PathAI Announces EMA Qualification for AIM-MASH AI Assist, a Groundbreaking AI Tool for MASH Clinical Trials
PathAI, a global leader in AI-powered pathology, today announced that the European Medicines Agency (EMA) Committee for ...
Business Insider3d
PathAI Announces EMA Qualification for AIM-MASH AI Assist, a Groundbreaking AI Tool for MASH Clinical Trials
BOSTON, March 20, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology ... serve as an aid to trial pathologists in scoring liver biopsies at enrollment and follow-up visits.
The Manila Times6d
A New Standard in Clinical Care for MASH Patients: HistoIndex Launches FibroSIGHT™
HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the ...
Morningstar6d
A New Standard in Clinical Care for MASH Patients: HistoIndex Launches FibroSIGHT™
SINGAPORE, March 17, 2025 /PRNewswire/ -- HistoIndex, a global leader in stain-free digital pathology ... associated steatotic liver disease (MASLD) characterized by steatosis and inflammation ...
Healio3d
Biomarkers identified by machine learning could assist in diagnosing liver diseases
Machine learning may help identify biomarkers and develop predictive models that could assist in the diagnosis of metabolic ...
Medscape4d
Rite of Passage or Road to Early Liver Damage?
This scoring is based on 14 g of alcohol ... and patients are most often detected due to abnormal liver chemistries or a finding of steatosis in the liver from an ultrasound performed for another ...
Yahoo Finance6d
A New Standard in Clinical Care for MASH Patients: HistoIndex Launches FibroSIGHT™
SINGAPORE, March 17, 2025 /PRNewswire/ -- HistoIndex, a global leader in stain-free digital pathology solutions for ... and accurate assessment of liver fibrosis." MASH has long been a challenging ...